Martin Shkreli

US FTC Wants Court to Hold “Pharma Bro” in Contempt

The Federal Trade Commission (FTC) has asked a US federal judge to hold “pharma bro” Martin Shkreli in contempt for forming another drug company that it said violates a January 2022 court order that banned him from working in the pharmaceutical industry

News

Turing Says it Will Cut Daraprim Price

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

INOSIM GmbH

Predictive Simulation in Pharma Production

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

From Catalogue to Collaboration

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.